Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information
Phone+43 (0) 1 - 236 657 611


Vienna, AUT
Gumpendorferstrasse 139 Top 1.05
Vienna, A-1060, AUT




Miracor Medical Systems

Based in Vienna, Austria, privately held Miracor is commercializing a unique and potentially disruptive technology, PICSO®, for acute coronary syndrome (ACS), heart failure, and cardiac surgery patients. The Company’s objective is to establish PICSO® as the standard of care for heart attack patients, thereby improving their quality of life. The initial market opportunity for PICSO® is 30% of all ACS patients treated per year, which translates into more than 350,000 patients in the U.S. and Europe.

The Miracor PICSO® Impulse System is CE-marked and can be used during coronary revascularization procedures following myocardial infarction and other types of acute coronary syndromes to intermittently increase the pressure in the coronary venous system. The technology is for investigational use only in the United States at this time.

Recent Milestones



Miracor Medical Systems screenshot
Above: Home Page
Uploaded: 2/29/12


  1. Miracor Secures 7M/$10M in Series B Financing Round ( [edit]
  2. Miracor Medical Systems Receives $3.5M from the Austrian Research Promotion Agency ( [edit]
Edit This Page
Last Edited 12/10/12

Revision History RSS Picture


Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API


Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy